1. Home
  2. ALXO vs TOPP Comparison

ALXO vs TOPP Comparison

Compare ALXO & TOPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALXO
  • TOPP
  • Stock Information
  • Founded
  • ALXO 2015
  • TOPP 2014
  • Country
  • ALXO United States
  • TOPP United States
  • Employees
  • ALXO N/A
  • TOPP N/A
  • Industry
  • ALXO Biotechnology: Pharmaceutical Preparations
  • TOPP
  • Sector
  • ALXO Health Care
  • TOPP
  • Exchange
  • ALXO Nasdaq
  • TOPP NYSE
  • Market Cap
  • ALXO 24.0M
  • TOPP 26.6M
  • IPO Year
  • ALXO 2020
  • TOPP 2025
  • Fundamental
  • Price
  • ALXO $0.61
  • TOPP $2.17
  • Analyst Decision
  • ALXO Strong Buy
  • TOPP
  • Analyst Count
  • ALXO 6
  • TOPP 0
  • Target Price
  • ALXO $3.30
  • TOPP N/A
  • AVG Volume (30 Days)
  • ALXO 500.5K
  • TOPP 12.7K
  • Earning Date
  • ALXO 08-07-2025
  • TOPP 08-11-2025
  • Dividend Yield
  • ALXO N/A
  • TOPP N/A
  • EPS Growth
  • ALXO N/A
  • TOPP N/A
  • EPS
  • ALXO N/A
  • TOPP N/A
  • Revenue
  • ALXO N/A
  • TOPP $16,117,227.00
  • Revenue This Year
  • ALXO N/A
  • TOPP N/A
  • Revenue Next Year
  • ALXO N/A
  • TOPP N/A
  • P/E Ratio
  • ALXO N/A
  • TOPP N/A
  • Revenue Growth
  • ALXO N/A
  • TOPP 0.44
  • 52 Week Low
  • ALXO $0.40
  • TOPP $0.97
  • 52 Week High
  • ALXO $6.08
  • TOPP $4.50
  • Technical
  • Relative Strength Index (RSI)
  • ALXO 61.99
  • TOPP N/A
  • Support Level
  • ALXO $0.44
  • TOPP N/A
  • Resistance Level
  • ALXO $0.64
  • TOPP N/A
  • Average True Range (ATR)
  • ALXO 0.04
  • TOPP 0.00
  • MACD
  • ALXO 0.01
  • TOPP 0.00
  • Stochastic Oscillator
  • ALXO 72.40
  • TOPP 0.00

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

About TOPP TOPPOINT HOLDINGS INC

Toppoint Holdings Inc is a truckload services and solutions provider focused on the recycling export supply chain. The company operates in one operating segment where it derives its revenues from the delivery of truckload services.

Share on Social Networks: